154 related articles for article (PubMed ID: 2849640)
1. Antitumor agents, 99. Synthetic ring C aromatized podophyllotoxin analogues as potential inhibitors of human DNA topoisomerase II.
Beers SA; Imakura Y; Dai HJ; Li DH; Cheng YC; Lee KH
J Nat Prod; 1988; 51(5):901-5. PubMed ID: 2849640
[TBL] [Abstract][Full Text] [Related]
2. Antitumor agents. I. DNA topoisomerase II inhibitory activity and the structural relationship of podophyllotoxin derivatives as antitumor agents.
Terada T; Fujimoto K; Nomura M; Yamashita J; Kobunai T; Takeda S; Wierzba K; Yamada Y; Yamaguchi H
Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2720-7. PubMed ID: 1334447
[TBL] [Abstract][Full Text] [Related]
3. A rational design strategy of the novel topoisomerase II inhibitors for the synthesis of the 4-O-(2-pyrazinecarboxylic)-4'-demethylepipodophyllotoxin with antitumor activity by diminishing the relaxation reaction of topoisomerase II-DNA decatenation.
Zhao W; Chen L; Li HM; Wang DJ; Li DS; Chen T; Yuan ZP; Tang YJ
Bioorg Med Chem; 2014 Jun; 22(11):2998-3007. PubMed ID: 24775914
[TBL] [Abstract][Full Text] [Related]
4. Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II.
Lee KH; Beers SA; Mori M; Wang ZQ; Kuo YH; Li L; Liu SY; Chang JY; Han FS; Cheng YC
J Med Chem; 1990 May; 33(5):1364-8. PubMed ID: 2158562
[TBL] [Abstract][Full Text] [Related]
5. Antitumor agents. 78. Inhibition of human DNA topoisomerase II by podophyllotoxin and alpha-peltatin analogues.
Thurston LS; Irie H; Tani S; Han FS; Liu ZC; Cheng YC; Lee KH
J Med Chem; 1986 Aug; 29(8):1547-50. PubMed ID: 3016271
[TBL] [Abstract][Full Text] [Related]
6. Antitumor agents. Part 232: Synthesis of cyclosulfite podophyllotoxin analogues as novel prototype antitumor agents.
Xiao Z; Han S; Bastow KF; Lee KH
Bioorg Med Chem Lett; 2004 Mar; 14(6):1581-4. PubMed ID: 15006408
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel podophyllotoxin analogs.
Li J; Hua HM; Tang YB; Zhang S; Ohkoshi E; Lee KH; Xiao Zy
Bioorg Med Chem Lett; 2012 Jul; 22(13):4293-5. PubMed ID: 22658864
[TBL] [Abstract][Full Text] [Related]
8. Podophyllotoxins: current status and recent developments.
Damayanthi Y; Lown JW
Curr Med Chem; 1998 Jun; 5(3):205-52. PubMed ID: 9562603
[TBL] [Abstract][Full Text] [Related]
9. Antitumor agents, 107. New cytotoxic 4-alkylamino analogues of 4'-demethyl-epipodophyllotoxin as inhibitors of human DNA topoisomerase II.
Lee KH; Imakura Y; Haruna M; Beers SA; Thurston LS; Dai HJ; Chen CH; Liu SY; Cheng YC
J Nat Prod; 1989; 52(3):606-13. PubMed ID: 2550587
[TBL] [Abstract][Full Text] [Related]
10. Antitumor agents. 125. New 4 beta-benzoylamino derivatives of 4'-O-demethyl-4-desoxypodophyllotoxin and 4 beta-benzoyl derivatives of 4'-O-demethylpodophyllotoxin as potent inhibitors of human DNA topoisomerase II.
Zhou XM; Wang ZQ; Chen HX; Cheng YC; Lee KH
Pharm Res; 1993 Feb; 10(2):214-9. PubMed ID: 8384366
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and potent cytotoxic activity of novel podophyllotoxin derivatives.
Li WQ; Wang XL; Qian K; Liu YQ; Wang CY; Yang L; Tian J; Morris-Natschke SL; Zhou XW; Lee KH
Bioorg Med Chem; 2013 Apr; 21(8):2363-2369. PubMed ID: 23490151
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 4β-N-polyaromatic substituted podophyllotoxins: DNA topoisomerase inhibition, anticancer and apoptosis-inducing activities.
Kamal A; Kumar BA; Suresh P; Agrawal SK; Chashoo G; Singh SK; Saxena AK
Bioorg Med Chem; 2010 Dec; 18(24):8493-500. PubMed ID: 21074444
[TBL] [Abstract][Full Text] [Related]
14. Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents.
Subrahmanyam D; Renuka B; Rao CV; Sagar PS; Deevi DS; Babu JM; Vyas K
Bioorg Med Chem Lett; 1998 Jun; 8(11):1391-6. PubMed ID: 9871772
[TBL] [Abstract][Full Text] [Related]
15. Antitumor agents. 124. New 4 beta-substituted aniline derivatives of 6,7-O,O-demethylene-4'-O-demethylpodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II.
Wang ZQ; Hu H; Chen HX; Cheng YC; Lee KH
J Med Chem; 1992 Mar; 35(5):871-7. PubMed ID: 1312601
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.
Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A
Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881
[TBL] [Abstract][Full Text] [Related]
17. Antitumor agents. 113. New 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II.
Wang ZQ; Kuo YH; Schnur D; Bowen JP; Liu SY; Han FS; Chang JY; Cheng YC; Lee KH
J Med Chem; 1990 Sep; 33(9):2660-6. PubMed ID: 2167985
[TBL] [Abstract][Full Text] [Related]
18. Antitumor agents, 130, Novel 4 beta-arylamino derivatives of 3',4'-didemethoxy-3',4'-dioxo-4-deoxypodophyllotoxin as potent inhibitors of human DNA topoisomerase II.
Zhang YL; Shen YC; Wang ZQ; Chen HX; Guo X; Cheng YC; Lee KH
J Nat Prod; 1992 Aug; 55(8):1100-11. PubMed ID: 1331331
[TBL] [Abstract][Full Text] [Related]
19. One-pot synthesis of podophyllotoxin-thiourea congeners by employing NH₂SO₃H/NaI: Anticancer activity, DNA topoisomerase-II inhibition, and apoptosis inducing agents.
Shankaraiah N; Kumar NP; Amula SB; Nekkanti S; Jeengar MK; Naidu VG; Reddy TS; Kamal A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4239-44. PubMed ID: 26292628
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. 126. Novel 4 beta-substituted anilino derivatives of 3',4'-O,O-didemethylpodophyllotoxin as potent inhibitors of human DNA topoisomerase II.
Wang ZQ; Shen YC; Chen HX; Chang JY; Guo X; Cheng YC; Lee KH
Pharm Res; 1993 Mar; 10(3):343-50. PubMed ID: 8385331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
